| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/03/2003 | WO2003000009A2 Stimulation of vascularization with vegf-b |
| 01/03/2003 | WO2003000006A2 Stackable low depth tray |
| 01/03/2003 | WO2002090595A9 Methods for modulating an immune response by modulating krc activity |
| 01/03/2003 | WO2002087605A3 Modified fvii in treatment of ards |
| 01/03/2003 | WO2002077155A3 Keratinocyte growth factor-2 |
| 01/03/2003 | WO2002076484A3 Combination of a taxane and a cyclin-dependent kinase inhibitor |
| 01/03/2003 | WO2002074247A8 Pharmaceutical formulations for sustained release |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002070594A3 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 01/03/2003 | WO2002070545A3 Siderophore analogues as tetra- or hexadentate iron chelators on the basis of amino acids or peptides, method for producing them and the use thereof |
| 01/03/2003 | WO2002066489A3 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002050248A3 Antisense modulation of hepsin expression |
| 01/03/2003 | WO2002046430A3 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| 01/03/2003 | WO2002045755A3 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 01/03/2003 | WO2002045754A3 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 01/03/2003 | WO2002045735A3 Nrp-derived peptides useful for treating insulin-dependent diabetes mellitus |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002044202A3 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 01/03/2003 | WO2002043647A3 Oncolytic virus |
| 01/03/2003 | WO2002042449A3 Method for selecting peptide ligands |
| 01/03/2003 | WO2002040635A9 HUMAN RNase H1 MUTANTS |
| 01/03/2003 | WO2002036628A3 New multimeric interferon beta polypeptides |
| 01/03/2003 | WO2002036078A3 Targeting pluripotent stem cells to tissues |
| 01/03/2003 | WO2002034213A3 Oral composition providing enhanced tooth stain removal |
| 01/03/2003 | WO2002031149A3 Polyvalent cation-sensing receptor proteins in aquatic species |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012500A3 Anti-il-12 antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002012329A3 Compositions and methods for the therapy and diagnosis of head and neck cancer |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002009699A3 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/03/2003 | WO2002008402A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 01/03/2003 | WO2002008187A9 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | WO2002005842A3 Preventing airway mucus production by administration of egf-r antagonists |
| 01/03/2003 | WO2002005835A3 Modulation of apoptosis |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000856A3 Protein glycosylation modification in pichia pastoris |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2003 | WO2001098512A3 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001098331A3 Glucagon-like peptide-1 analogs |
| 01/03/2003 | WO2001096370A3 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001075068A3 Secreted proteins and polynucleotides encoding them |
| 01/03/2003 | WO2001057272A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta |
| 01/03/2003 | WO2001057251A3 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| 01/03/2003 | CA2790034A1 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2460809A1 Polynucleotide vaccine |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2454882A1 Chimeric capsid proteins and uses thereof |
| 01/03/2003 | CA2451839A1 Pharmaceutical compositions comprising peptides and permeation enhancers |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451311A1 Stimulation of vascularization with vegf-b |
| 01/03/2003 | CA2451310A1 Antimicrobial peptides |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451239A1 Antibodies against tumor-associated antigenic taget (tat) polypeptides |
| 01/03/2003 | CA2451091A1 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450957A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | CA2450950A1 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | CA2450947A1 Black soybean polysaccharides |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450828A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | CA2450783A1 Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same |
| 01/03/2003 | CA2450562A1 Tyrosine kinase inhibitors |
| 01/03/2003 | CA2450449A1 Pharmaceutical formulation |
| 01/03/2003 | CA2450446A1 Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof |
| 01/03/2003 | CA2449990A1 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | CA2449439A1 Particles for inhalation having rapid release properties |
| 01/03/2003 | CA2447941A1 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | CA2447249A1 Abin-mediated hepatitis protection |
| 01/03/2003 | CA2442710A1 Human secreted proteins |
| 01/02/2003 | US20030005474 Transgenic rodent for use as tool in the diagnosis and treatment of nervous system disorders |
| 01/02/2003 | US20030005471 PAR, a novel marker gene for breast and prostate cancers |
| 01/02/2003 | US20030004327 Cerebellum and embryo specific protein |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004320 Activated peptides and conjugates |
| 01/02/2003 | US20030004315 Collagen |
| 01/02/2003 | US20030004314 Autoimmune diseases; rheumatic disorders |
| 01/02/2003 | US20030004311 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004309 Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component |
| 01/02/2003 | US20030004308 Anticoagulants |